Literature DB >> 25239448

Potential clinical treatment for Ebola pandemic.

Ying Zhong1, Jun Xu, TaiSheng Li, XueZhong Yu, MiaoMiao Sheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25239448      PMCID： PMC7088662          DOI： 10.1007/s11427-014-4756-5

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
  15 in total

1.  Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Authors:  Travis K Warren; Kelly L Warfield; Jay Wells; Dana L Swenson; Kelly S Donner; Sean A Van Tongeren; Nicole L Garza; Lian Dong; Dan V Mourich; Stacy Crumley; Donald K Nichols; Patrick L Iversen; Sina Bavari
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

2.  Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo.

Authors:  Wonhwa Lee; Sae-Kwang Ku; Jong-Sup Bae
Journal:  Food Chem Toxicol       Date:  2012-06-18       Impact factor: 6.023

3.  High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.

Authors:  Luke S Uebelhoer; César G Albariño; Laura K McMullan; Ayan K Chakrabarti; Joel P Vincent; Stuart T Nichol; Jonathan S Towner
Journal:  Antiviral Res       Date:  2014-04-05       Impact factor: 5.970

Review 4.  Crimean-Congo hemorrhagic fever.

Authors:  Chris A Whitehouse
Journal:  Antiviral Res       Date:  2004-12       Impact factor: 5.970

5.  Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.

Authors:  Lisa Oestereich; Anja Lüdtke; Stephanie Wurr; Toni Rieger; César Muñoz-Fontela; Stephan Günther
Journal:  Antiviral Res       Date:  2014-02-26       Impact factor: 5.970

6.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Authors:  Gene Garrard Olinger; James Pettitt; Do Kim; Cara Working; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael Pauly; Kevin J Whaley; Calli M Lear; Julia E Biggins; Corinne Scully; Lisa Hensley; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

7.  Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.

Authors:  Basak Dokuzoguz; Aysel Kocagül Celikbas; Şebnem Eren Gök; Nurcan Baykam; Mustafa Necati Eroglu; Önder Ergönül
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

8.  Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial).

Authors:  Jaimin M Patel; Catherine Snaith; David R Thickett; Lucie Linhartova; Teresa Melody; Peter Hawkey; Anthony H Barnett; Alan Jones; Tan Hong; Matthew W Cooke; Gavin D Perkins; Fang Gao
Journal:  Crit Care       Date:  2012-12-11       Impact factor: 9.097

9.  The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.

Authors:  Gerrit Gehring; Katrin Rohrmann; Nkacheh Atenchong; Eva Mittler; Stephan Becker; Franziska Dahlmann; Stefan Pöhlmann; Florian W R Vondran; Sascha David; Michael P Manns; Sandra Ciesek; Thomas von Hahn
Journal:  J Antimicrob Chemother       Date:  2014-04-07       Impact factor: 5.790

10.  Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

Authors:  Travis K Warren; Jay Wells; Rekha G Panchal; Kelly S Stuthman; Nicole L Garza; Sean A Van Tongeren; Lian Dong; Cary J Retterer; Brett P Eaton; Gianluca Pegoraro; Shelley Honnold; Shanta Bantia; Pravin Kotian; Xilin Chen; Brian R Taubenheim; Lisa S Welch; Dena M Minning; Yarlagadda S Babu; William P Sheridan; Sina Bavari
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962
View more
  2 in total

Review 1.  Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.

Authors:  Everardo González-González; Mario Moisés Alvarez; Alan Roberto Márquez-Ipiña; Grissel Trujillo-de Santiago; Luis Mario Rodríguez-Martínez; Nasim Annabi; Ali Khademhosseini
Journal:  Crit Rev Biotechnol       Date:  2015-11-26       Impact factor: 8.429

2.  Impact of major disease outbreaks in the third millennium on adolescent and youth sexual and reproductive health and rights in low and/or middle-income countries: a systematic scoping review protocol.

Authors:  Hossein Akbarialiabad; Rahul Shidhaye; Pallavi Shidhaye; Pim Cuijpers; Marcia R Weaver; Mina Bahrololoom; Sarah Kiburi; Irene N Njuguna; Mohammad Hossein Taghrir; Manasi Kumar
Journal:  BMJ Open       Date:  2022-03-11       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.